KraneShares Emerging Markets Healthcare Index
|
- Description
- Performance
- Comps
Fundamentals
Valuation
Rating
KMED seeks to provide investment results that, before fees and expenses, track the performance of the Solactive Emerging Markets Healthcare Index. The index seeks to track the equity market performance of companies engaged in the health care sector in various emerging markets. |
Category | Emerging Market Equities |
Fund Sponsor | KraneShares |
Website | kraneshares.com |
Inception date | Aug 29, 2018 |
Assets (mns) | $1 |
Currency | USD |
Expense ratio | 79 bp |
Distributions | Semi-annual |
Regulation | Open-Ended Fund |
Custodian | |
Weighting | Market Cap |
Index replication | |
Uses derivatives | No |
Options available | No |
No. of constituents | 76 |
Wgt avg mkt cap (mns) | $8,965 |
Large cap (>$10bn) | 43.4% |
Mid cap ($2-10bn) | 47.8% |
Small cap (<$2bn) | 7.7% |
Developed mkts | 6.5% |
Emerging mkts | 93.5% |
SUN PHARMACEUTICAL INDUS | 5.0 % |
BANGKOK DUSIT MED SERVICE | 4.7 % |
SAMSUNG BIOLOGICS CO., LTD. | 4.5 % |
JIANGSU HENGRUI MEDICINE CO., LTD. | 4.4 % |
CELLTRION INC | 4.3 % |
IHH HEALTHCARE BHD | 4.2 % |
HAPVIDA PARTICIPACOES E INVESTIMEN | 3.8 % |
NOTRE DAME INTERMEDICA PARTICIPACO | 2.8 % |
AIER EYE HOSPITAL GROUP CO., LTD. | 2.7 % |
WUXI BIOLOGICS (CAYMAN) INC. | 2.7 % | Total | 39.1 % |
---|
![]() |
CHINA | 27.7 % |
![]() |
SOUTH KOREA | 19.4 % |
![]() |
INDIA | 11.7 % |
![]() |
BRAZIL | 9.1 % |
![]() |
MALAYSIA | 6.8 % |
![]() |
THAILAND | 6.0 % |
![]() |
INDONESIA | 2.9 % |
![]() |
SOUTH AFRICA | 2.9 % |
![]() |
HUNGARY | 1.3 % |
![]() |
MEXICO | 0.4 % |
HISTORICAL PERFORMANCE 

Custom date range | Compare to | ||
thru |
Year-to-date | 1 year | 5 years | 10 years | Since Incep. |
5.6% | -1.3% | -- | -- | -11.7% |
versus... | Beta | R-squared |
S&P500 | 0.90 | 50% |
MSCI EAFE | 1.21 | 63% |
MSCI Emg. Mkts. | 1.00 | 60% |
Recent close | $21.42 |
30d moving avg. | $21.97 |
Annualized volatility | 22.3% |
Short interest (ETF) | 0.0% |
Relative strength (RSI) | 46 |
Avg. volume (thou.) | 0 |
Turnover | 0.0% |
Bid/Ask (% of price) | 1.02% |
ADV underlying (mns) | $1,958 |
FINDING ALTERNATIVE FUNDS
Below is a list of 20 potential alternatives to the KraneShares Emerging Markets Healthcare Index ETF based on the alternatives' overlap in portfolio holdings with KMED. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.
Benchmark ticker: | KMED | Expense: | 79 bp | ALTAR Score™: | 3.5% |
Ticker | Fund Name |
Overlap1 vs KMED (%) |
Expense ratio (bp) |
Savings vs KMED (bp) |
ALTAR Score™ (%) |
ALTAR vs KMED (%) |
KURE | KraneShares MSCI All China Health Care | 25.0 | 65 | 14 | 4.4 | +0.8 |
CHIH | Global X MSCI China Health Care | 16.6 | 65 | 14 | 5.2 | +1.7 |
CHNA | Loncar China BioPharma | 7.4 | 79 | 0 | 5.0 | +1.5 |
CNXT | VanEck Vectors China AMC SME-ChiNext | 5.9 | 65 | 14 | 5.5 | +2.0 |
FLKR | Franklin FTSE South Korea | 5.7 | 9 | 70 | 10.7 | +7.2 |
EWY | iShares MSCI Korea | 5.7 | 59 | 20 | 10.2 | +6.7 |
EWM | iShares MSCI Malaysia | 5.2 | 47 | 32 | 7.1 | +3.6 |
MXDE | Nationwide Maximum Diversification Emg Mkts Core | 5.1 | 64 | 15 | 5.2 | +1.7 |
IPOS | Renaissance International IPO | 4.9 | 80 | -1 | 5.7 | +2.2 |
PEK | VanEck Vectors ChinaAMC A-Shares | 4.9 | 60 | 19 | 9.2 | +5.7 |
CXSE | WisdomTree China ex-State Owned Enterprises | 4.8 | 32 | 47 | 7.0 | +3.5 |
ASHR | Xtrackers Harvest CSI 300 China A-Shares | 4.8 | 65 | 14 | 9.2 | +5.7 |
FPXI | First Trust International IPO | 4.8 | 70 | 9 | 3.9 | +0.4 |
BICK | First Trust BICK Index Fund | 4.4 | 64 | 15 | 5.6 | +2.1 |
ASHX | Xtrackers MSCI China A Inclusion | 4.1 | 60 | 19 | 8.8 | +5.3 |
CNYA | iShares MSCI China A | 4.0 | 65 | 14 | 9.3 | +5.8 |
KBA | KraneShares MSCI China A Int'l | 3.9 | 60 | 19 | 8.8 | +5.3 |
EDOG | ALPS Emerging Sector Dividend Dogs | 3.8 | 60 | 19 | 9.3 | +5.8 |
FDEM | Fidelity Targeted Emerging Markets Factor | 3.6 | 45 | 34 | 8.8 | +5.3 |
AFTY | CSOP FTSE China A50 | 3.2 | 70 | 9 | 11.2 | +7.7 |
1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.
Content on this tab for subscribers only**
RESULTS & ESTIMATES
2014 | 2015 | 2016 | 2017 | 2018 | 2019E | 2020E | |
---|---|---|---|---|---|---|---|
Sales per share | ** | ** | ** | ** | ** | ** | ** |
Earnings per share | ** | ** | ** | ** | ** | ** | ** |
Dividends per share ![]() |
** | ** | ** | ** | ** | ** | ** |
Book value per share | ** | ** | ** | ** | ** | ** | ** |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
OTHER FUNDAMENTAL METRICS
Long term EPS growth est. | **% | Debt-to-equity | **x | |
Asset turnover | **% | Assets-to-equity | **x |
*Six months ago = 100 |
Content on this tab for subscribers only
VALUATION METRICS
2018 | 2019E | 2020E | |
---|---|---|---|
Price-to-sales | ** | ** | ** |
Price-to-earnings | ** | ** | ** |
Price-to-cash flow | ** | ** | ** |
Price-to-growth | ** | ** | ** |
Price-to-book value | ** | ** | ** |
Yield | ** | ** | ** |
Historical valuation trends
Forward multiple: |
KraneShares Emerging Markets Healthcare Index | |||
Relative to: |
S&P500 | MSCI EAFE | MSCI Emg. Mkts. | Other ETF: |
AVOID |
Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
ALTAR Score™
|
MODERN PORTFOLIO THEORY
![]() |
CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
|